Cervical cancer could be all but eliminated in 80 years: Lancet study

RACGP News, 20 Feb 2019

The Lancet Oncology modelling study found 149 of 181 countries could cut rates of the preventable cancer to four per 100,000 women by the end of the century – the threshold for considering it eliminated as a public health problem.

The study finds that combining high uptake of the vaccine with high screening could prevent up to 13.4 million cases of cervical cancer within 50 years, with the most benefit in low and middle income countries.

 

Stillbirth more frequent in women with HIV in UK than in general population

nam/aidsmap, 01 August 2017

The stillbirth rate among women living with HIV in the UK and Ireland from 2007 to 2015 was more than twice that of the general population, Graziella Favarato, presenting on behalf of the National Study of HIV in Pregnancy and Childhood (NSHPC), told participants at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris last week.

Most women originated from a sub-Saharan African country, accounting for 0.9% of stillbirths (71/7752) while stillbirth among women from Europe or westernised countries accounted for 0.4% (8/2004).

Pregnancy problems are leading global killer of ​​females aged 15 to 19

The Guardian, Tuesday 16 May 2017

Pregnancy complications are the leading cause of death globally among females aged 15-19, with self-harm in second place, a global study has found.

More than 1.2 million female and male adolescents die annually, the World Health roaOrganization (WHO) report said – the majority from preventable causes including mental health issues, poor nutrition, reproductive health problems and violence.

 

New kind of male contraceptive faces biggest hurdle: drugmakers

The Age,  Published 

Doctors are on the cusp of launching the first new male contraceptive in more than a century. But rather than a Big Pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India.

Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval. Results so far show it’s safe, effective and easy to use – but gaining little traction with drugmakers.

Two-drug HIV therapy just as effective as three-drug therapy

aidsmap/nam, 25 October 2016

SImplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).

Read more here 

Contraceptive rates in poorest countries leap by 30 million users in four years

Guardian, Tuesday 1 November 2016

The number of women in the world’s poorest countries using modern forms of contraception has jumped by more than 30 million in the past four years, according to a report that found the most significant progress had been made in sub-Saharan Africa.

At the halfway point of the Family Planning 2020 (FP2020) initiative, launched in 2012, around 12 million more women and girls were using contraceptives in east, south and west Africa.